Hsbc Holdings PLC Taro Pharmaceutical Industries LTD Transaction History

Hsbc Holdings PLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$40.97 - $43.33 $3.91 Million - $4.13 Million	95,317 New	95,317 $4.04 Million
Q1 2021 May 14, 2021	SELL	$70.48 - $79.95 $815,594 - $925,181	-11,572 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$54.4 - $73.42 $38,896 - $52,495	715 Added 6.59%	11,572 $0
Q2 2020 Aug 14, 2020	SELL	$61.66 - $70.16 $281,354 - $320,140	-4,563 Reduced 29.59%	10,857 $722,000
Q3 2019 Nov 14, 2019	SELL	$75.36 - $86.57 $1.12 Million - $1.28 Million	-14,841 Reduced 49.04%	15,420 $1.16 Million
Q2 2019 Aug 13, 2019	BUY	$83.92 - $108.88 $539,102 - $699,445	6,424 Added 26.95%	30,261 $2.59 Million
Q1 2019 May 15, 2019	BUY	$85.97 - $108.09 $462,862 - $581,956	5,384 Added 29.18%	23,837 $2.58 Million
Q4 2018 Feb 13, 2019	BUY	$78.25 - $107.92 $1.44 Million - $1.99 Million	18,453 New	18,453 $1.56 Million
Q4 2017 Feb 14, 2018	SELL	$104.5 - $126.38 $286,016 - $345,902	-2,737 Closed	0 $0
Q3 2017 Nov 14, 2017	SELL	$97.26 - $116.2 $39,195 - $46,828	-403 Reduced 12.83%	2,737 $308,000
Q2 2017 Aug 14, 2017	BUY	N/A	3,140	3,140 $352,000

17K

Ticker TARO
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 37,584,600
Description
Taro Pharmaceutical Industries Ltd., a science-based pharmaceutical company, develops, manufactures, and markets prescription and over-the-counter pharmaceutical products in the United States, Canada, Israel, and internationally. The company also develops and manufactures active pharmaceutical ingredients primarily for use in its finished dosage...

Get notified when there are updates to the investment portfolio of Hsbc Holdings PLC, based on Form 13F filings with the SEC.

Stay updated on Hsbc Holdings PLC with notifications on news.